3,3-环戊烷戊二酰亚胺 | 1130-32-1

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氮杂螺癸烷衍生物
• 中文名称: 3,3-环戊烷戊二酰亚胺
• 中文别名: 3,3-环戊烷-4-丁内酰胺
• 英文名称: 3-azaspiro[5.5]undecane-2,4-dione
• 英文别名: 3,3-pentamethylene glutarimide
• CAS: 1130-32-1
• 化学式: C₁₀H₁₅NO₂
• mdl: MFCD00023872
• 分子量: 181.235
• InChiKey: FNIPRNMPSXNBDI-UHFFFAOYSA-N

物化性质

• 熔点：
  84-89 °C(lit.)
• 沸点：
  362.3±11.0 °C(Predicted)
• 密度：
  1.14±0.1 g/cm3(Predicted)
• 溶解度：
  可溶于DMSO（少许）、甲醇（少许）
• 稳定性/保质期：
  如果按照规格使用和储存，则不会分解，没有已知危险反应，应避免与氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  46.2
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• WGK Germany：
  3
• RTECS号：
  CM0120000
• 海关编码：
  2925190090
• 安全说明：
  S22,S24/25
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  保持贮藏器密封，并将其存放在阴凉、干燥处。确保工作间有良好的通风或排气装置。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3,3-Pentamethylene glutarimide
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3,3-Pentamethylene glutarimide
CAS number: 1130-32-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H15NO2
Molecular weight: 181.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途：用于制备药物加巴喷丁的中间体。

反应信息

• 作为反应物：
  描述：

  3,3-环戊烷戊二酰亚胺 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 反应 16.5h， 生成 3-氮螺环[5,5]十一烷
  参考文献：
  名称：

  从饱和氮杂环得到 N-稠合杂环的 C–H/C–C 官能化方法

  摘要：

  在此，我们报道了通过连续的 CH 和 CC 键功能化，从简单的饱和环胺合成取代的吲哚里西啶和相关的 N-稠合双环。受 Norrish-Yang II 型反应的启发，氮杂环化合物的 CH 官能化是通过在温和的可见光条件下由前体 α-酮酰胺衍生物形成 α-羟基-β-内酰胺来实现的。使用Rh复合物选择性裂解α-羟基-β-内酰胺中的远端C(sp2)--C(sp3)键产生α-酰基中间体，该中间体经历连续的Rh催化脱羰基化，1,4加成到亲电子试剂和羟醛环化，得到包括吲哚里西啶的 N-稠合自行车。计算研究为观察到的 CC 裂解的位置选择性提供了机制上的见解，这在很大程度上取决于与膦配体的 Rh 反式结合的基团。

  DOI：

  10.1021/jacs.0c04278
• 作为产物：
  描述：

  1,1-环己基二乙酸 在 ammonium hydroxide 、 硫酸 作用下， 以 5,5-dimethyl-1,3-cyclohexadiene 为溶剂， 反应 7.0h， 生成 3,3-环戊烷戊二酰亚胺
  参考文献：
  名称：

  一种1,1-环己烷-二乙酸单酰胺的制备方法及其应用

  摘要：

  本发明公开了一种1,1‑环己烷‑二乙酸单酰胺(CDMA)的制备方法，包括在非苯的非极性溶剂中，1,1‑环己基二乙酸酐和1,1‑环己烷‑二乙酸单酰胺铵盐进行酰胺化反应，得到1,1‑环己烷‑二乙酸单酰胺(CDMA)；或者，在非苯的非极性溶剂中，1,1‑环己基二乙酸酐与氨加热回流反应，得到3,3‑环戊烷戊二酰亚胺；3,3‑环戊烷戊二酰亚胺经碱水解开环得到1,1‑环己烷‑二乙酸单酰胺(CDMA)。其中，以1,1‑环己基二乙酸为起始原料，在酸催化下脱水得到1,1‑环己基二乙酸酐。

  公开号：

  CN113444011A

文献信息

• [EN] AMIDOALKYLPIPERAZINYL DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES<br/>[FR] DÉRIVÉS D'AMIDOALKYLPIPÉRAZINYLE POUR LE TRAITEMENT DE MALADIES DU SYSTÈME NERVEUX CENTRAL
  申请人：ADAMED SP ZOO

  公开号：WO2013001498A1

  公开（公告）日：2013-01-03

  The invention relates to novel amidoalkylpiperazinyl derivatives of tricyclic heterocyclic systems of general formula (I), wherein Z represents -NH- and X represents -S-, or Z represents -S- and X represents >C=C<; R1 represents H or -CH3, R6 and R7 both represent H, n is an integer from 0 to 4 inclusive, G represents a cyclic amide or imide moiety, and optical isomers, geometric isomers, and pharmaceutically acceptable salts thereof. The compounds may be useful for the treatment and/or prevention of the central nervous system disorders.

  该发明涉及一种新型三环杂环系统的酰胺基烷基哌嗪衍生物，其一般式为（I），其中Z代表-NH-，X代表-S-，或Z代表-S-，X代表>C=C<；R1代表H或-CH3，R6和R7均代表H，n为0至4的整数，G代表环酰胺或亚酰胺基团，以及其光学异构体、几何异构体和药学上可接受的盐。这些化合物可能对中枢神经系统疾病的治疗和/或预防有用。
• Synthesis and biological evaluation of a series of multi-target N-substituted cyclic imide derivatives with potential antipsychotic effect
  作者：Mingshuo Xu、Yu Wang、Feipu Yang、Chunhui Wu、Zhen Wang、Bin Ye、Xiangrui Jiang、Qingjie Zhao、Jianfeng Li、Yongjian Liu、Junchi Zhang、Guanghui Tian、Yang He、Jingshan Shen、Hualiang Jiang

  DOI：10.1016/j.ejmech.2017.12.099

  日期：2018.2

  In the present study, a series of multi-target N-substituted cyclic imide derivatives which possessed potent dopamine D2, serotonin 5-HT1A and 5-HT2A receptors properties were synthesized and evaluated as potential antipsychotics. Among these compounds, (3aR,4R,7S,7aS)-2-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione hydrochloride (3d)

  在本研究中，其具有强效的多巴胺d一系列多目标的N-取代环状酰亚胺衍生物的2，血清素5-HT 1A和5-HT 2A受体的性质，合成并评价潜在的抗精神病药物。在这些化合物中，（3aR，4R，7S，7aS）-2-（4-（4-（4-苯并[ b ]噻吩-4-基）哌嗪-1-基）丁基）-3a，4,7,7a-四氢-1H-4,7-甲基异吲哚-1,3（2H）-二酮盐酸盐（3d）具有良好的药理作用。3d不仅在D 2 / 5-HT 1A / 5-HT 2A上显示出强大而平衡的体外活性受体，但在5-HT 2C，H 1，α1A，M 3受体和hERG通道上也具有低至中度的活性，提示引起副作用（如体重增加，体位性低血压和QT延长）的责任低。在动物行为研究中，3d降低了苯环利定诱发的运动过度，并导致僵直症的诱导阈值较高。化合物3d被选作潜在的抗精神病药物，可用于进一步开发。
• Effect of catalytic alkali metal bromide on Hofmann-type rearrangement of imides
  作者：Katsuhiko Moriyama、Kazuma Ishida、Hideo Togo

  DOI：10.1039/c2cc33914e

  日期：——

  The Hofmann-type rearrangement of aromatic and aliphatic imides using KBr as the catalyst proceeded to provide aromatic and aliphatic amino acid derivatives. We have also developed a new synthetic route to gabapentin with this method.

  使用KBr作为催化剂的芳族和脂族酰亚胺的霍夫曼型重排进行以提供芳族和脂族氨基酸衍生物。我们还开发了这种方法合成加巴喷丁的新合成途径。
• Lead Optimization of Phthalazinone Phosphodiesterase Inhibitors as Novel Antitrypanosomal Compounds
  作者：Irene G. Salado、Abhimanyu K. Singh、Carlos Moreno-Cinos、Guna Sakaine、Marco Siderius、Pieter Van der Veken、An Matheeussen、Tiffany van der Meer、Payman Sadek、Sheraz Gul、Louis Maes、Geert-Jan Sterk、Rob Leurs、David Brown、Koen Augustyns

  DOI：10.1021/acs.jmedchem.9b00985

  日期：2020.4.9

  Human African trypanosomiasis is causing thousands of deaths every year in the rural areas of Africa. In this manuscript we describe the optimization of a family of phtalazinone derivatives. Phosphodiesterases have emerged as attractive molecular targets for a novel treatment for a variety of neglected parasitic diseases. Compound 1 resulted in being a potent TbrPDEB1 inhibitor with interesting activity

  非洲人类锥虫病每年在非洲农村地区造成数千人死亡。在此手稿中，我们描述了酞菁酮衍生物家族的优化。磷酸二酯酶已成为一种有吸引力的分子靶标，可用于治疗多种被忽视的寄生虫病。化合物1导致作为一种有效的抑制剂TbrPDEB1用针对令人感兴趣的活性布氏锥虫在表型筛选。在急性体内小鼠疾病模型中对衍生物1进行了研究，但不幸的是，由于代谢稳定性低，它没有显示出任何功效。我们报道了结构修饰，以实现具有改善的代谢稳定性的化合物，同时保持针对TbrPDEB1和布氏锥虫。化合物14在小鼠和人微粒体中表现出良好的微粒体稳定性，并为以后的工作提供了良好的起点。
• <i>N</i>-Acyl-glutarimides: Effect of Glutarimide Ring on the Structures of Fully Perpendicular Twisted Amides and N–C Bond Cross-Coupling
  作者：Md. Mahbubur Rahman、Chengwei Liu、Elwira Bisz、Błażej Dziuk、Roger Lalancette、Qi Wang、Hao Chen、Roman Szostak、Michal Szostak

  DOI：10.1021/acs.joc.0c00227

  日期：2020.4.17

  demonstrates the generality of deploying N-acyl-glutarimides to achieve full twist of the acyclic amide bond, and results in the discovery of N-acyl-glutarimide amide with an almost perfect twist value, τ = 89.1°. X-ray structures of five new N-acyl-glutarimides are reported. Reactivity studies in the Suzuki–Miyaura cross-coupling and transamidation reactions provide insight into the reactivity of N-acyl-glutarimides

  迄今为止，N-酰基戊二酰亚胺已成为N-C（O）键交叉偶联反应中最具反应性的前体，其中反应性是由酰胺键的基态失稳驱动的。在本文中，我们报告了对戊二酰亚胺环对完全垂直的N-酰基-戊二酰亚胺酰胺的结构，电子性质和反应性的影响的全面研究。最值得注意的是，该报告证明了部署N-酰基-戊二酰亚胺酰胺以完全扭转无环酰胺键的普遍性，并导致发现了N-酰基-戊二酰亚胺酰胺具有几乎完美的扭转值，τ= 89.1°。五个新N的X射线结构报道了酰基-戊二酰亚胺。Suzuki-Miyaura交叉偶联和氨基转移反应中的反应性研究提供了N-酰基戊二酰亚胺在金属催化和无过渡金属反应中的反应性的见解。讨论了扭曲，结构和围绕N–C（O）轴的旋转障碍的影响。实现酰胺键完全变形的能力大大扩展了可用于N–C（O）交叉偶联反应的试剂范围。